Respiri – executive interview

Published on 22 September 2022

Respiri is an ASX-listed company developing software as a service (SaaS) diagnostic solutions to support respiratory health management. The company’s technology detects wheeze, a typical symptom of asthma, chronic obstructive pulmonary disease and respiratory disease, to provide an objective measure of airway limitation. In this video, CEO Marjan Mikel provides an overview of the company’s strategy and approach.

Share this with friends and colleagues